The aim of the research conducted at The Babraham Institute is to study the molecular mechanisms that underlie normal cellular processes and functions, and to understand how these systems are affected by age. The Institute's work also covers how faults or abnormalities in these systems may contribute to disease. The Institute has the status of a postgraduate department within the
University of Cambridge and trains
PhD students who are registered with the University's Faculty of Biology. The research laboratories of the Institute are structured around three strategic programmes: •
Signalling (headed by Simon Cook): focuses on proteins that play a critical role in controlling communication between and within cells. These proteins make up the
signalling pathways that organise how cells and organs develop and react to their environment. •
Immunology (headed by
Martin Turner): investigates signal transduction pathways that regulate the survival and activation of lymphocytes. •
Epigenetics (headed by Gavin Kelsey): studies how epigenetic information is introduced into the genome during early development of an organism, which can in part depend on environmental or nutritional factors acting through cell signalling pathways. Research breakthroughs made at the Babraham Institute include the discovery of
liposomes by
Alec Bangham, the role of
Inositol trisphosphate in the release of
calcium from intracellular stores by
Michael Berridge, the discovery that
genomic imprinting was carried by DNA methylation by
Wolf Reik. Many of its past and current employees were elected fellows of the
Royal Society, including (in date order) Drs
Sir Rudolph Albert Peters (1935),
Ivan de Burgh Daly (1943),
Sir John Henry Gaddum (1945),
Marthe Vogt (1952),
Richard Darwin Keynes (1959), Sir Barry Cross (1975),
Rex Malcolm Chaplin Dawson (1981),
Sir Robert Brian Heap (1989), M Azim Surani (1990), Robin Francis Irvine (1993), Jonathan Charles Howard (1995),
Wolf Reik (2010),
Len Stephens (2011),
Phil Hawkins (2013). Babraham Institute Enterprise Ltd (BIE), the wholly owned trading subsidiary of the Babraham Institute promotes knowledge transfer and translation of the Institute’s research discoveries, actively managing and exploiting the Institute’s intellectual property, promoting and negotiating commercial research partnerships and establishing spin-out companies when appropriate. == Funding ==